Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Knight

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Speech, Language, and Hearing Research : JSLHR|September 8, 2016
Patient-Reported Measures of Hearing Loss and Tinnitus in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic ReviewDaniel Stark, Abby R Rosenberg, Donna Johnston, et al.
Perspectives of the ASHA Special Interest Groups|March 31, 2025
What's New in Ototoxicity Management?Katharine A Fernandez, Angela Garinis, Kristin Knight, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|July 17, 2025
Bone Anchored Hearing Aid With Headband Over Cranial Orthosis: A Pilot StudyAna E Meza-Rochin, Gwendolyn E Daly, Miracle Uzoekwe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology GroupWendy Landier, Kristin Knight, F Lennie Wong, et al.
The Lancet. Oncology|December 5, 2016
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trialDavid R Freyer, Lu Chen, Mark D Krailo, et al.
The Lancet. Child & Adolescent Health|December 24, 2019
Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guidelineDavid R Freyer, Penelope R Brock, Kay W Chang, et al.
Neuro-Oncology Practice|November 17, 2022
Surveillance of long-term complications after treatment of adult brain tumor survivors-review and evidence-based recommendationsKarl Cristie F Figuracion, Lia M Halasz, Ny-Ying Lam, et al.
Pediatric Blood & Cancer|February 11, 2023
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use itPenelope Brock, Annelot Meijer, Per Kogner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2024
Self-terminating, heterogeneous solid-electrolyte interphase enables reversible Li-ether cointercalation in graphite anodesDawei Xia, Heonjae Jeong, Dewen Hou, et al.
Drug Delivery|May 2, 2026
Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic reviewAmirhossein Masroor, Nienke Streefkerk, Martine Van Grotel, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Speech, Language, and Hearing Research : JSLHR|September 8, 2016
Patient-Reported Measures of Hearing Loss and Tinnitus in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic ReviewDaniel Stark, Abby R Rosenberg, Donna Johnston, et al.
Perspectives of the ASHA Special Interest Groups|March 31, 2025
What's New in Ototoxicity Management?Katharine A Fernandez, Angela Garinis, Kristin Knight, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|July 17, 2025
Bone Anchored Hearing Aid With Headband Over Cranial Orthosis: A Pilot StudyAna E Meza-Rochin, Gwendolyn E Daly, Miracle Uzoekwe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology GroupWendy Landier, Kristin Knight, F Lennie Wong, et al.
The Lancet. Oncology|December 5, 2016
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trialDavid R Freyer, Lu Chen, Mark D Krailo, et al.
The Lancet. Child & Adolescent Health|December 24, 2019
Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guidelineDavid R Freyer, Penelope R Brock, Kay W Chang, et al.
Neuro-Oncology Practice|November 17, 2022
Surveillance of long-term complications after treatment of adult brain tumor survivors-review and evidence-based recommendationsKarl Cristie F Figuracion, Lia M Halasz, Ny-Ying Lam, et al.
Pediatric Blood & Cancer|February 11, 2023
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use itPenelope Brock, Annelot Meijer, Per Kogner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2024
Self-terminating, heterogeneous solid-electrolyte interphase enables reversible Li-ether cointercalation in graphite anodesDawei Xia, Heonjae Jeong, Dewen Hou, et al.
Drug Delivery|May 2, 2026
Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic reviewAmirhossein Masroor, Nienke Streefkerk, Martine Van Grotel, et al.
Pageof 3